Stage IIIC Rectal Cancer Withdrawn Phase 1 / 2 Trials for Oxybuprocaine (DB00892)

IndicationStatusPhase
DBCOND0028694 (Stage IIIC Rectal Cancer)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02575508Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerTreatment